Cargando…
Evaluation of Interferon Inducers, Ribavirin and Mouse Hyperimmune Serum in a Pathogenesis/Lethal Mouse Model Using a Mouse-adapted SARS-CoV
Autores principales: | Barnard, Dale, Day, Craig, Wandersee, Miles, Kumaki, Yohichi, Salazar, Andres |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133852/ http://dx.doi.org/10.1016/j.antiviral.2008.01.025 |
Ejemplares similares
-
Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol(®) (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model
por: Kumaki, Yohichi, et al.
Publicado: (2017) -
Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication in a Lethal SARS-Cov Balb/C Mouse Model by Stinging Nettle Lectin, Urtica Dioica Agglutinin (UDA)
por: Kumaki, Yohichi, et al.
Publicado: (2010) -
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
por: Kumaki, Yohichi, et al.
Publicado: (2011) -
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
por: Day, Craig W., et al.
Publicado: (2009) -
Prophylactic Efficacy of Intranasally Administered HSP Nanoparticles for Treating a Lethal SARS-CoV Infection in BALB/c Mice
por: Barnard, Dale, et al.
Publicado: (2009)